Top compounds associated with response to OR4C12


Feature Type Standardized
Nominal ANOVA
mRNA sitagliptin CTRPv2 pan-cancer AAC -0.077 0.3
mRNA HC-067047 CTRPv2 pan-cancer AAC -0.039 0.3
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.037 0.3
mRNA SB 505124 GDSC1000 pan-cancer AAC -0.035 0.3
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.037 0.3
mRNA tamatinib CTRPv2 pan-cancer AAC -0.038 0.3
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.037 0.3
mRNA Dasatinib GDSC1000 pan-cancer AAC 0.05 0.3
mRNA Bicalutamide GDSC1000 pan-cancer AAC -0.034 0.3
mRNA Tipifarnib GDSC1000 pan-cancer AAC -0.036 0.3
Download CSV